Neuroprotective Agents

"Neuroprotective Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.

Descriptor ID	D018696
MeSH Number(s)	D27.505.696.706.548 D27.505.954.427.575
Concept/Terms	Neuroprotective Agents Neuroprotective Agents Agents, Neuroprotective Neuroprotectants Neuroprotective Drugs Drugs, Neuroprotective Neuroprotective Effect Neuroprotective Effect Effect, Neuroprotective Neuroprotective Effects Effects, Neuroprotective

Below are MeSH descriptors whose meaning is more general than "Neuroprotective Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Protective Agents [D27.505.696.706]
Neuroprotective Agents [D27.505.696.706.548]
Therapeutic Uses [D27.505.954]
Central Nervous System Agents [D27.505.954.427]
Neuroprotective Agents [D27.505.954.427.575]

Below are MeSH descriptors whose meaning is more specific than "Neuroprotective Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neuroprotective Agents" by people in this website by year, and whether "Neuroprotective Agents" was a major or minor topic of these publications.

Bar chart showing 51 publications over 20 distinct years, with a maximum of 5 publications in 2007 and 2010 and 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	1	2
2003	1	0	1
2004	1	1	2
2006	3	1	4
2007	5	0	5
2008	2	1	3
2009	3	1	4
2010	5	0	5
2011	4	1	5
2012	2	0	2
2013	0	1	1
2014	1	1	2
2015	2	0	2
2016	2	1	3
2017	1	1	2
2018	1	0	1
2019	2	0	2
2020	2	1	3
2021	1	0	1
2022	1	0	1

Below are the most recent publications written about "Neuroprotective Agents" by people in Profiles.

Paul DA, Rodrigue A, Contento N, Haber S, Hoang R, Rahmani R, Hirad A, Shafiq I, Williams Z, Vates GE. Prolactin at moderately increased levels confers a neuroprotective effect in non-secreting pituitary macroadenomas. PLoS One. 2022; 17(8):e0271690.

View in: PubMed
Canseco JA, Karamian BA, Bowles DR, Markowitz MP, DiMaria SL, Semenza NC, Leibensperger MR, Smith ML, Vaccaro AR. Updated Review: The Steroid Controversy for Management of Spinal Cord Injury. World Neurosurg. 2021 06; 150:1-8.

View in: PubMed
Farf?n N, Carril J, Redel M, Zamorano M, Araya M, Monz?n E, Alvarado R, Contreras N, Tapia-Bustos A, Quintanilla ME, Ezquer F, Vald?s JL, Israel Y, Herrera-Marschitz M, Morales P. Intranasal Administration of Mesenchymal Stem Cell Secretome Reduces Hippocampal Oxidative Stress, Neuroinflammation and Cell Death, Improving the Behavioral Outcome Following Perinatal Asphyxia. Int J Mol Sci. 2020 Oct 21; 21(20).

View in: PubMed
Creed J, Cantillana-Riquelme V, Yan BH, Ma S, Chu D, Wang H, Turner DA, Laskowitz DT, Hoffmann U. Argon Inhalation for 24?h After Closed-Head Injury Does not Improve Recovery, Neuroinflammation, or Neurologic Outcome in Mice. Neurocrit Care. 2021 06; 34(3):833-843.

View in: PubMed
Ammar MJ, Hsu J, Chiang A, Ho AC, Regillo CD. Age-related macular degeneration therapy: a review. Curr Opin Ophthalmol. 2020 May; 31(3):215-221.

View in: PubMed
Ma S, Chu D, Li L, Creed JA, Ryang YM, Sheng H, Yang W, Warner DS, Turner DA, Hoffmann U. Argon Inhalation for 24 Hours After Onset of Permanent Focal Cerebral Ischemia in Rats Provides Neuroprotection and Improves Neurologic Outcome. Crit Care Med. 2019 08; 47(8):e693-e699.

View in: PubMed
Brenneman DE, Kinney WA, Ward SJ. Knockdown siRNA Targeting the Mitochondrial Sodium-Calcium Exchanger-1 Inhibits the Protective Effects of Two Cannabinoids Against Acute Paclitaxel Toxicity. J Mol Neurosci. 2019 Aug; 68(4):603-619.

View in: PubMed
Adeghate J, Rahmatnejad K, Waisbourd M, Katz LJ. Intraocular pressure-independent management of normal tension glaucoma. Surv Ophthalmol. 2019 Jan - Feb; 64(1):101-110.

View in: PubMed
Ward SJ, Castelli F, Reichenbach ZW, Tuma RF. Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia. Life Sci. 2018 Feb 15; 195:1-5.

View in: PubMed
Ilieva H, Maragakis NJ. Motoneuron Disease: Clinical. Adv Neurobiol. 2017; 15:191-210.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement